Atrandi Biosciences develops droplet microfluidics technology that enables efficient generation, manipulation, and sorting of droplets for high-throughput single-cell analysis. Their semi-permeable capsules facilitate multi-step molecular workflows, allowing researchers to encapsulate and analyze tens of thousands of single cells without loss of compartmentalization.
Funding
$7.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Single-cell analysis often requires complex, multi-step molecular workflows that are difficult to perform without losing compartmentalization of individual cells. Traditional methods struggle to efficiently encapsulate and analyze large numbers of single cells, hindering high-throughput screening and analysis.
Solution
Atrandi Biosciences offers droplet microfluidics technology that simplifies and accelerates single-cell analysis. Their ONYX droplet generator and STYX HTS platform enable effortless droplet generation, manipulation, and high-throughput sorting. Semi-permeable capsules facilitate multi-step molecular workflows by encapsulating tens of thousands of single cells, maintaining compartmentalization even during harsh lysis steps. This turnkey microfluidics solution allows researchers to perform comprehensive microfluidics-based screening with convenient droplet collection and compatibility between the ONYX and STYX platforms.
Target Audience
The primary audience includes researchers and laboratories involved in single-cell analysis, microfluidics, and high-throughput screening.
Features
- ONYX droplet generator combines pumps, microscope, high-speed camera, and high-voltage power source for easy droplet generation and manipulation.
- STYX HTS platform combines fluorescence analysis, droplet manipulation, and user-friendly software for droplet cytometry and selection.
- Semi-permeable capsules support multi-step molecular analysis without loss of single-cell compartmentalization.
- Simultaneous encapsulation of up to 8 samples into biocompatible SPCs in minutes.
- SPCs are stable under various reaction conditions and suitable for downstream reactions using standard laboratory equipment.
- Ready-to-use kits for droplet generation and manipulation ensure reliable results.